- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02670902
Intervention for Persons Leaving Residential Substance Abuse Treatment
October 31, 2022 updated by: New York University
Intervention for Persons With Co-Occurring Disorders Leaving Residential Tx
This research uses a multi-phase approach to adapt and implement an established intervention, Critical Time Intervention, for a new population and setting among individuals with substance use who are at risk of relapse following residential substance abuse treatment.
The goals of the study are to: (PHASE 1) identify challenges and strategies of community reentry among individuals in residential substance abuse treatment and their providers and social support networks (e.g., family, friends, community members); (PHASE 2) adapt CTI for individuals in residential substance abuse treatment to prepare them for discharge and transition back into the community; and (PHASE 3) conduct a pilot study to examine the feasibility, acceptability, and preliminary outcomes of the adapted CTI compared to enhanced usual discharge planning services.
Study Overview
Status
Completed
Conditions
Detailed Description
This randomized pilot study will examine the feasibility, acceptability, and preliminary outcomes of the adapted CTI compared to enhanced usual discharge planning services.
More specifically, 60 participants will be randomized to either CTI (n=30) or enhanced usual discharge planning services (n=30) at the time of discharge.
Participants will complete a baseline interview (prior to randomization) and 3-, 6-, 9- and 12-month follow-up assessments post-discharge.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10003
- New York University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Eligible participants will be enrolled in residential substance abuse treatment and who are at least 18 years of age, speak English, and expect to be discharged within 3 months.
Exclusion Criteria:
Individuals that do not meet the aforementioned inclusion criteria will be excluded from the study.More specifically, the following categories will be excluded:
- Anyone under the age of 18
- Non-English speaking individuals due to limited resources
- Individuals who are considered vulnerable/protected populations, including children, pregnant women, and prisoners.
- Individuals judged by clinical treatment staff to be in immediate crisis, i.e., suicide watch or inadequate decisional capacity to participate in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Critical Time Intervention-Residential
CTI-R is a 9-month, assertive outreach and linkage program.
|
CTI-R is a 9-month, time-limited intervention that aims to produce an enduring impact by effectively linking individuals to both professional services (substance abuse and health and mental health providers) and social supports (e.g., family and friends) and by providing emotional and practical support.
Participants in the CTI-R condition will also receive usual discharge services from the residential substance abuse treatment program.
The enhanced usual discharge condition encompasses the regular discharge services offered at the residential treatment program plus enhanced transition services.
|
|
Active Comparator: Enhanced Usual Discharge-Residential
The enhanced usual discharge condition includes usual discharge services plus enhanced transition services.
|
The enhanced usual discharge condition encompasses the regular discharge services offered at the residential treatment program plus enhanced transition services.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Enrollment
Time Frame: Baseline
|
Proportion of participants enrolled in the study as measured by the research records
|
Baseline
|
|
Change in retention
Time Frame: 3, 6, 9, and 12 months
|
Proportion of participants completed the study as measured by the research records
|
3, 6, 9, and 12 months
|
|
Short-term Relapse
Time Frame: 3 months
|
Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index
|
3 months
|
|
Use of aftercare services
Time Frame: 3 months
|
Proportion of participants who were linked to aftercare services (i.e.
substance use treatment) at the time of discharge as measured by the Treatment Service Review (TSR)
|
3 months
|
|
Housing
Time Frame: 3 months
|
Proportion of participants housed at the time of discharge
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short-term Social Support
Time Frame: 3 months
|
Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey
|
3 months
|
|
Short-term Self-Efficacy
Time Frame: 3 months
|
Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."
|
3 months
|
|
Short-term Mental Health
Time Frame: 3 months
|
Level of mental health severity as measured by the Brief Symptom Inventory
|
3 months
|
|
Change in Relapse
Time Frame: 3, 6, and 9 months
|
Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index
|
3, 6, and 9 months
|
|
Long-term Relapse
Time Frame: 12 months
|
Proportion of participants who relapsed (i.e., substance use) as measured by Addiction Severity Index
|
12 months
|
|
Change in Social Support
Time Frame: 3, 6, and 9 months
|
Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey
|
3, 6, and 9 months
|
|
Long-term Social Support
Time Frame: 12 months
|
Level of social support as measured by the 8-item modified Medical Outcomes Study Social Support Survey
|
12 months
|
|
Change in Self-Efficacy
Time Frame: 3, 6, and 9 months
|
Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."
|
3, 6, and 9 months
|
|
Long-term Self-Efficacy
Time Frame: 12 months
|
Level of self-efficacy as measured by "I feel like I'm in control of my alcohol or drug use."
|
12 months
|
|
Change in Mental Health
Time Frame: 3, 6, and 9 months
|
Level of mental health severity as measured by the Brief Symptom Inventory
|
3, 6, and 9 months
|
|
Long-term Mental Health
Time Frame: 12 months
|
Level of mental health severity as measured by the Brief Symptom Inventory
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jennifer I Manuel, PhD, New York University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2017
Primary Completion (Actual)
May 1, 2020
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
January 25, 2016
First Submitted That Met QC Criteria
February 1, 2016
First Posted (Estimate)
February 2, 2016
Study Record Updates
Last Update Posted (Actual)
November 1, 2022
Last Update Submitted That Met QC Criteria
October 31, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- K01DA035330 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
University of ArkansasNational Center for Advancing Translational Sciences (NCATS)RecruitingParenting | Substance Use Treatment | Perinatal Substance UseUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Substance Use DisordersUnited States
-
Spark Biomedical, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA); Baylor College... and other collaboratorsRecruitingSubstance Use Disorders | Alcohol Use Disorder | Alcohol Abuse | Substance Use Disorders Alcohol Use Withdrawal StateUnited States
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorders | Nicotine Use DisorderUnited States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
Clinical Trials on Critical Time Intervention-Residential (CTI-R)
-
Columbia UniversityNational Institute of Mental Health (NIMH)CompletedSchizophrenia | Psychotic DisorderBrazil, Chile
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)CompletedPsychotic DisordersUnited States
-
VA Office of Research and DevelopmentUniversity of California, Los Angeles; University of Southern California; Center...Enrolling by invitation
-
University of Maryland, BaltimoreNational Institute on Drug Abuse (NIDA)CompletedMood Disorders | Schizophrenia | Substance DependenceUnited States
-
New York State Psychiatric InstituteMontefiore Medical Center; Healthfirst; Bronx-Lebanon Hospital Center Health...TerminatedSchizophrenia | Medical ComplicationUnited States
-
Nathan Kline Institute for Psychiatric ResearchNational Institute of Mental Health (NIMH)Completed
-
VA Connecticut Healthcare SystemWithdrawnConditions: Serious Mental Illness
-
Lisbon Institute of Global Mental Health - LIGMHColumbia UniversityRecruitingPsychotic Disorders | Schizophrenia | Bipolar Disorder | Schizo Affective DisorderPortugal
-
Stony Brook UniversityBoston University; University of Puerto Rico; University of Central FloridaRecruitingHealth Harming Legal NeedsUnited States
-
New York State Psychiatric InstituteCompleted